Nationwide Fund Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-25,881
| Closed | -$1.05M | – | 610 |
|
|
2017
Q3 | $1.05M | Sell |
25,881
-1,101
| -4% | -$44.5K | ﹤0.01% | 1746 |
|
|
2017
Q2 | $915K | Sell |
26,982
-18,954
| -41% | -$643K | ﹤0.01% | 1829 |
|
|
2017
Q1 | $1.33M | Sell |
45,936
-8,482
| -16% | -$246K | 0.01% | 1595 |
|
|
2016
Q4 | $1.79M | Buy |
54,418
+3,175
| +6% | +$104K | 0.01% | 1457 |
|
|
2016
Q3 | $1.62M | Buy |
51,243
+7,600
| +17% | +$240K | 0.01% | 1496 |
|
|
2016
Q2 | $1.23M | Sell |
43,643
-2,961
| -6% | -$83.2K | 0.01% | 1606 |
|
|
2016
Q1 | $1.69M | Sell |
46,604
-272
| -0.6% | -$9.89K | 0.01% | 1429 |
|
|
2015
Q4 | $1.88M | Sell |
46,876
-30,745
| -40% | -$1.23M | 0.01% | 1390 |
|
|
2015
Q3 | $2.21M | Hold |
77,621
| – | – | 0.01% | 1308 |
|
|
2015
Q2 | $2.56M | Sell |
77,621
-9,841
| -11% | -$324K | 0.01% | 1302 |
|
|
2015
Q1 | $2.52M | Sell |
87,462
-4,313
| -5% | -$124K | 0.01% | 1335 |
|
|
2014
Q4 | $2.5M | Sell |
91,775
-318
| -0.3% | -$8.66K | 0.01% | 1298 |
|
|
2014
Q3 | $1.96M | Buy |
92,093
+222
| +0.2% | +$4.73K | 0.01% | 1447 |
|
|
2014
Q2 | $2.06M | Buy |
91,871
+19,459
| +27% | +$437K | 0.01% | 1455 |
|
|
2014
Q1 | $1.83M | Buy |
72,412
+42,400
| +141% | +$1.07M | 0.01% | 1415 |
|
|
2013
Q4 | $690K | Sell |
30,012
-558
| -2% | -$12.8K | ﹤0.01% | 2077 |
|
|
2013
Q3 | $582K | Buy |
30,570
+5,959
| +24% | +$113K | ﹤0.01% | 2145 |
|
|
2013
Q2 | $355K | Buy |
+24,611
| New | +$355K | ﹤0.01% | 2198 |
|